These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11041705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
    Sterling TR, Alwood K, Gachuhi R, Coggin W, Blazes D, Bishai WR, Chaisson RE.
    AIDS; 1999 Oct 01; 13(14):1899-904. PubMed ID: 10513648
    [Abstract] [Full Text] [Related]

  • 3. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F, Chaisson RE, Matts JP, Miller C, de Lourdes Garcia M, Hafner R, Valdespino JL, Coberly J, Schechter M, Klukowicz AJ, Barry MA, O'Brien RJ.
    JAMA; 2000 Mar 15; 283(11):1445-50. PubMed ID: 10732934
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa.
    Kassim S, Sassan-Morokro M, Ackah A, Abouya LY, Digbeu H, Yesso G, Coulibaly IM, Coulibaly D, Whitaker PJ, Doorly R.
    AIDS; 1995 Oct 15; 9(10):1185-91. PubMed ID: 8519456
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multidrug-resistant tuberculosis and its control.
    Kochi A, Vareldzis B, Styblo K.
    Res Microbiol; 1993 Feb 15; 144(2):104-10. PubMed ID: 8337467
    [No Abstract] [Full Text] [Related]

  • 8. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
    Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection Society.
    J Infect; 2009 Sep 15; 59(3):167-87. PubMed ID: 19643501
    [Abstract] [Full Text] [Related]

  • 9. Reply: Treatment of tuberculosis in HIV-infected patients.
    Pozniak AL, Ormerod LP, Miller R.
    AIDS; 1999 Jul 30; 13(11):1431-2. PubMed ID: 10449310
    [No Abstract] [Full Text] [Related]

  • 10. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A, Burman W, Benator D, Khan A, Bozeman L.
    Lancet; 1999 May 29; 353(9167):1843-7. PubMed ID: 10359410
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team.
    Perlman DC, El Sadr WM, Heifets LB, Nelson ET, Matts JP, Chirgwin K, Salomon N, Telzak EE, Klein O, Kreiswirth BN, Musser JM, Hafner R.
    AIDS; 1997 Oct 29; 11(12):1473-8. PubMed ID: 9342069
    [Abstract] [Full Text] [Related]

  • 12. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.
    Johnson JL, Okwera A, Hom DL, Mayanja H, Mutuluuza Kityo C, Nsubuga P, Nakibali JG, Loughlin AM, Yun H, Mugyenyi PN, Vernon A, Mugerwa RD, Ellner JJ, Whalen CC, Uganda-Case Western Reserve University Research Collaboration.
    AIDS; 2001 Nov 09; 15(16):2137-47. PubMed ID: 11684933
    [Abstract] [Full Text] [Related]

  • 13. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.
    Probl Tuberk Bolezn Legk; 2004 Nov 09; (3):32-7. PubMed ID: 15338898
    [Abstract] [Full Text] [Related]

  • 14. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis.
    March F, Garriga X, Rodríguez P, Moreno C, Garrigó M, Coll P, Prats G.
    Clin Infect Dis; 1997 Nov 09; 25(5):1044-7. PubMed ID: 9402354
    [Abstract] [Full Text] [Related]

  • 15. Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia.
    Mwinga A, Hosp M, Zulu I, Farthing MJ, Mulambo S, Kelly P.
    AIDS; 2002 Mar 29; 16(5):806-8. PubMed ID: 11964547
    [No Abstract] [Full Text] [Related]

  • 16. [Tuberculosis].
    Bonnaud F, Zigani A.
    Rev Prat; 2002 Oct 15; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract] [Full Text] [Related]

  • 17. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
    Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R, Chaisson RE.
    Lancet; 1998 Mar 14; 351(9105):786-92. PubMed ID: 9519950
    [Abstract] [Full Text] [Related]

  • 18. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep 14; 49(4):327-45. PubMed ID: 8000420
    [Abstract] [Full Text] [Related]

  • 19. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
    Krüüner A, Pehme L, Ghebremichael S, Koivula T, Hoffner SE, Mikelsaar M.
    Clin Infect Dis; 2002 Jul 15; 35(2):146-55. PubMed ID: 12087520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.